News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Smiths Medical, Inc. Offers Innovative Technology that Reduces the Need for Occlusion De-clotting Medication


5/14/2013 11:07:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today that there is an alternative product that decreases catheter occlusions, a common problem with IV catheters. Smiths Medical distributes Nexus TKO® (To Keep Open) needleless connectors, a solution that can help healthcare facilities affected by the current supply constraint of the occlusion de-clotting medication Cathflo® Activase® (alteplase)2.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES